Issue 44, 2016, Issue in Progress

Preparation and characterization of magnetic nanoparticles and their impact on anticancer drug binding and release processes moderated through a 1st tier dendrimer

Abstract

Magnetic nanoparticle accumulated dendrimers (MADs) have been prepared using a 1 : 1 ratio of MNPs and trimesoyl 1,3,5-trimethyl malonate ester (TTDMM), a 1st tier dendrimer, in ethanolic medium at 100 °C on refluxing for 24 h. The MADs formed were characterized for their structural, functional and morphological properties using XRD, VSM, FTIR, SEM-EDX, TEM and DLS techniques. The MNPs show superparamagnetic character which moderates the structural ability of TTDMM to bind silibinin (SB) and methotrexate (MTX) anticancer drugs for their potential use in drug delivery systems. In this context, the MADs have shown higher silibinin and methotrexate binding activities compared to those of the dendrimer only, which are confirmed through FTIR, DLS and SEM-EDX. An UV-Vis spectrophotometry study shows 32.65% and 53.03% in vitro release of SB and MTX respectively at 10 h, in PBS with a 10% DMSO (PD) medium at 37 °C. Furthermore, chemosensitivity testing of MAD was carried out on a human lung cancer cell line (A549) using a sulforhodamine B (SRB) assay. The test showed that the newly developed drug delivery system for SB and MTX inhibits the growth of A549 human lung cancer cells by 13.9% and 44.3% respectively with 80 μg mL−1 of the total complex. The results of our study have provided new insight for developing MADs as a potential carrier for anticancer drugs with a controlled and sustained release tendency.

Graphical abstract: Preparation and characterization of magnetic nanoparticles and their impact on anticancer drug binding and release processes moderated through a 1st tier dendrimer

Supplementary files

Article information

Article type
Paper
Submitted
24 Jan 2016
Accepted
22 Mar 2016
First published
15 Apr 2016

RSC Adv., 2016,6, 37391-37402

Author version available

Preparation and characterization of magnetic nanoparticles and their impact on anticancer drug binding and release processes moderated through a 1st tier dendrimer

S. R. Pandya and M. Singh, RSC Adv., 2016, 6, 37391 DOI: 10.1039/C6RA02139E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements